Wegovy (semaglutide injection): This once-weekly injectable is the hallmark of GLP-1 weight loss medications, reducing body weight by an average of 14.9% in trials
What they did: They transected the quadriceps (front thigh) of rats and divided them into three groups: Control, no drugs Dexamethasone, a potent corticosteroid that is known to impair healing Dexamethasone + BPC-157 What they found: Dexamethasone group: 50 % worse healing than control (confirmed negative effect of steroids) Dexamethasone + BPC-157 group: healing at the level of controls without steroids Why it matters: This is a highly clinically relevant finding
[DOI] [PubMed] [Google Scholar] 176.Osakada F., Hashino A., Kume T., Katsuki H., Kaneko S., Akaike A
While not FDA-approved for longevity enhancement, its used in supervised medical protocols for healthspan optimization and biological age management
Application is typically twice daily to the scalp, though once-daily use shows benefit with better compliance for many people